|

Cardonilizumab Clinical Trials

2 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 2: 2

Top Sponsors

  • Tongji Hospital1
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Indications

  • Cancer2
  • Chemoradiotherapy1
  • Induction Therapy1
  • Esophageal Squamous Cell Carcinoma1
  • Surgery1

Other2 trials

Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer
Phase 2
Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.